CMS released the CY2027 Medicare Advantage Final Rule and Rate Announcement within four days of each other. Together, they represent a systematic restructuring of how Medicare Advantage organizations will compete, be evaluated, and be paid. This guide covers six areas of change: what shifted, what’s at stake,
Read More →
Charles Baker, VP, Compliance Solutions Over the past three years, CMS hasn’t shouted, but it has indeed spoken. Quietly, steadily, and now unmistakably, the agency has cranked up oversight of Medicare Advantage and Part D plans. And the 2024 audit cycle? It’s not just louder— it’s broader, sharper,
Read More →
Charles Baker, VP, Compliance Solutions Tammy Hall, Sr. Consultant, Compliance & Health Plan Operations Introduction The 2026 Contract Year Final Rule for Medicare Advantage (MA) and Part D Prescription Drug Plans largely fell flat in comparison to previous rule making cycles in contrast to the 2026 Proposed
Read More →December 5, 2024 issue of RADAR on Medicare Advantage Multiple industry experts say the current administration’s last major Medicare Advantage and Part D rulemaking attempt was largely “business as usual,” with CMS expanding on policies of the Joe Biden presidency and digging further into persistent issues like
Read More →Exceeding 950 pages in its initial prepublication version, CMS’s most recent rule proposing policy and technical changes for contract year 2024 is the Biden administration’s most complicated and sweeping Medicare Advantage and Part D rule to date. Following a comprehensive request for information issued last summer on
Read More →
